Annals of Thoracic Medicine Official publication of the Saudi Thoracic Society, affiliated to King Saud University
 
Search Ahead of print Current Issue Archives Instructions Subscribe e-Alerts Login 
Home Email this article link Print this article Bookmark this page Decrease font size Default font size Increase font size
This article has been cited by
1Survival impact of node zone classification in resected pathological N2 non-small cell lung cancer
T. Baba,H. Uramoto,T. Kuwata,Y. Chikaishi,M. Nakagawa,T. So,T. Hanagiri,F. Tanaka
Interactive CardioVascular and Thoracic Surgery.2012;14(6)760
[DOI]
2Surgery for Stage IIIA Non–Small-cell Lung Cancer: Lack of Predictive and Prognostic Factors Identifying Any Subgroup of Patients Benefiting From It
Branislav Jeremic,Francesc Casas,Pavol Dubinsky,Antonio Gomez-Caamano,Nikola Cihoric,Greg Videtic
Clinical Lung Cancer.2016;17(2)107
[DOI]
3Prognostic potential of ERCC1 protein expression and clinicopathologic factors in stage III/N2 non-small cell lung cancer
Dong Yan,Ping Wei,Guangyu An,Wenming Chen
Journal of Cardiothoracic Surgery.2013;8(1)107
[DOI]
4Neoadjuvant Chemoradiotherapy vesus Chemotherapy alone Followed by Surgery for Resectable Stage III Non-Small-Cell Lung Cancer: a Meta-Analysis
Shan xian Guo,Yan Jian,Ying lan Chen,Yun Cai,Qing yuan Zhang,Fang fang Tou
Scientific Reports.2016;6(1)107
[DOI]
5Variability in the Treatment of Elderly Patients with Stage IIIA (N2) Non–Small-Cell Lung Cancer
Mark F. Berry,Mathias Worni,Ricardo Pietrobon,Thomas A. D'Amico,Igor Akushevich
Journal of Thoracic Oncology.2013;8(6)744
[DOI]
6Prognostic factors for overall survival of stage III non-small cell lung cancer patients on computed tomography: A systematic review and meta-analysis
Myra van Laar,Wouter A.C. van Amsterdam,Anne S.R. van Lindert,Pim A. de Jong,Joost J.C. Verhoeff
Radiotherapy and Oncology.2020;151(6)152
[DOI]
7Induction Chemoradiation Is Not Superior to Induction Chemotherapy Alone in Stage IIIA Lung Cancer
Asad A. Shah,Mark F. Berry,Ching Tzao,Mihir Gandhi,Mathias Worni,Ricardo Pietrobon,Thomas A. D'Amico
The Annals of Thoracic Surgery.2012;93(6)1807
[DOI]
8Treatment-Related Predictive and Prognostic Factors in Trimodality Approach in Stage IIIA/N2 Non-Small Cell Lung Cancer
Branislav Jeremic,Francesc Casas,Pavol Dubinsky,Antonio Gomez-Caamano,Nikola Cihoric,Gregory Videtic,Ivan Igrutinovic
Frontiers in Oncology.2018;8(6)1807
[DOI]
9Neoadjuvant and adjuvant therapy for Stage III non-small cell lung cancer
Shun-ichi Watanabe,Kazuo Nakagawa,Kenji Suzuki,Kazuya Takamochi,Hiroyuki Ito,Jiro Okami,Keiju Aokage,Hisashi Saji,Hiroshige Yoshioka,Yoshitaka Zenke,Tadashi Aoki,Yasuhiro Tsutani,Morihito Okada
Japanese Journal of Clinical Oncology.2017;47(12)1112
[DOI]
10Adding radiation to induction chemotherapy does not improve survival of patients with operable clinical N2 non–small cell lung cancer
Chi-Fu Jeffrey Yang,Brian C. Gulack,Lin Gu,Paul J. Speicher,Xiaofei Wang,David H. Harpole,Mark W. Onaitis,Thomas A. D'Amico,Mark F. Berry,Matthew G. Hartwig
The Journal of Thoracic and Cardiovascular Surgery.2015;150(6)1484
[DOI]
  About the journal 
  Editorial Board 
  Saudi Thoracic Society(STS)
  Announcements 
  Most popular articles 
  My Preferences 

Submit Articles

Alerts

Join us

Most pupular articles